Indian Supreme Court Dismisses Novartis’ Patent Claim for Its Cancer Drug

by Kathy Jones on  April 1, 2013 at 6:05 PM Medico Legal News
RSS Email Print This Page Comment bookmark
Font : A-A+

Swiss pharmaceutical giants Novartis has received a huge blow to its Indian operations after the country's Supreme Court dismissed a patent request for its cancer drug, Glivec.
 Indian Supreme Court Dismisses Novartis’ Patent Claim for Its Cancer Drug
Indian Supreme Court Dismisses Novartis’ Patent Claim for Its Cancer Drug

The Supreme Court ruled that the compound for which Novartis was seeking a patent "did not satisfy the test of novelty or inventiveness" required by Indian law.

Show Full Article


Source: AFP

Post a Comment

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
Notify me when reply is posted
I agree to the terms and conditions

Recommended Reading

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

News Category

News Archive